Research programme: neuronal nicotinic receptor modulators - Targacept

Drug Profile

Research programme: neuronal nicotinic receptor modulators - Targacept

Alternative Names: TC-2429; TC-7020; TC-8831

Latest Information Update: 14 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Targacept
  • Class Quinuclidines; Small molecules
  • Mechanism of Action Alpha7 nicotinic acetylcholine receptor agonists; Nicotinic receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Cognition disorders; Drug-induced dyskinesia; Parkinson's disease; Schizophrenia

Most Recent Events

  • 31 Mar 2015 Discontinued - Preclinical for Cognition disorders in USA (unspecified route)
  • 31 Mar 2015 Discontinued - Preclinical for Drug-induced dyskinesia in USA (unspecified route)
  • 31 Mar 2015 Discontinued - Preclinical for Parkinson's disease in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top